» Articles » PMID: 15004061

Evaluation of the Fully Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium Tuberculosis to Pyrazinamide, Streptomycin, Isoniazid, Rifampin, and Ethambutol and Comparison with the Radiometric BACTEC 460TB Method

Overview
Specialty Microbiology
Date 2004 Mar 9
PMID 15004061
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The performance of the fully automated BACTEC MGIT 960 (M960) system for the testing of Mycobacterium tuberculosis susceptibility to streptomycin (SM), isoniazid (INH), rifampin (RMP), ethambutol (EMB), and pyrazinamide (PZA) was evaluated with 100 clinical isolates and compared to that of the radiometric BACTEC 460TB (B460) system. The agar proportion method and the B460 system were used as reference methods to resolve the discordant results for SM, INH, RMP, and EMB (a combination known as SIRE) and PZA, respectively. The overall agreements were 96.3% for SIRE and 92% for PZA. For SIRE, a total of 26 discrepancies were found and were resolved in favor of the M960 system in 8 cases and in favor of the B460 system in 18 cases. The M960 system produced 8 very major errors (VME) and 10 major errors (ME), while the B460 system showed 4 VME and 4 ME. No statistically significant differences were found. Both systems exhibited excellent performance, but a higher number of VME was observed with the M960 system at the critical concentrations of EMB and SM. For PZA, a total of eight discrepancies were observed and were resolved in favor of the M960 system in one case and in favor of the B460 system in seven cases; no statistically significant differences were found. The M960 system showed four VME and three ME. The mean times to report overall PZA results and resistant results were 8.2 and 9.8 days, respectively, for the M960 system and 7.4 and 8.1 days, respectively, for the B460 system. Statistically significant differences were found. The mean times to report SIRE results were 8.3 days for the M960 system and 8.2 days for the B460 system. No statistically significant differences were found. Twelve strains tested for SIRE susceptibility and seven strains tested for PZA susceptibility had been reprocessed because of contamination. In conclusion, the M960 system can represent a valid alternative to the B460 for M. tuberculosis susceptibility testing; however, the frequent contamination of the tests needs to be improved.

Citing Articles

A simplified pyrazinamidase test for pyrazinamide antimicrobial susceptibility testing.

Chan H, Wang Y, Jou R J Clin Microbiol. 2024; 62(12):e0122724.

PMID: 39555932 PMC: 11633146. DOI: 10.1128/jcm.01227-24.


Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities.

Chin K, Anibarro L, Chang Z, Palasuberniam P, Mustapha Z, Sarmiento M Curr Res Microb Sci. 2024; 7:100295.

PMID: 39512261 PMC: 11541417. DOI: 10.1016/j.crmicr.2024.100295.


Small RNA datasets of drug-susceptible strains from Sabah, Malaysia.

Jumat M, Jani J, Mustapha Z, Rodrigues K, Azizan N, Acosta A Data Brief. 2022; 46:108795.

PMID: 36483477 PMC: 9723821. DOI: 10.1016/j.dib.2022.108795.


Review and Updates on the Diagnosis of Tuberculosis.

Huang Y, Ai L, Wang X, Sun Z, Wang F J Clin Med. 2022; 11(19).

PMID: 36233689 PMC: 9570811. DOI: 10.3390/jcm11195826.


Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis.

Shi D, Zhou Q, Xu S, Zhu Y, Li H, Xu Y Infect Drug Resist. 2022; 15:4985-4994.

PMID: 36065280 PMC: 9440668. DOI: 10.2147/IDR.S368444.


References
1.
Brunello F, Fontana R . Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs. J Clin Microbiol. 2000; 38(2):872-3. PMC: 86230. DOI: 10.1128/JCM.38.2.872-873.2000. View

2.
Ruiz P, Zerolo F, Casal M . Comparison of susceptibility testing of Mycobacterium tuberculosis using the ESP culture system II with that using the BACTEC method. J Clin Microbiol. 2000; 38(12):4663-4. PMC: 87660. DOI: 10.1128/JCM.38.12.4663-4664.2000. View

3.
Bemer P, Palicova F, Rusch-Gerdes S, Drugeon H, Pfyffer G . Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2002; 40(1):150-4. PMC: 120114. DOI: 10.1128/JCM.40.1.150-154.2002. View

4.
Ardito F, Posteraro B, Sanguinetti M, Zanetti S, Fadda G . Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2001; 39(12):4440-4. PMC: 88562. DOI: 10.1128/JCM.39.12.4440-4444.2001. View

5.
Rusch-Gerdes S, Domehl C, Nardi G, Gismondo M, Welscher H, Pfyffer G . Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol. 1998; 37(1):45-8. PMC: 84164. DOI: 10.1128/JCM.37.1.45-48.1999. View